Zobrazeno 1 - 10
of 53
pro vyhledávání: '"Joel M. Kaufman"'
Autor:
Joel M. Kaufman
Publikováno v:
Neurology. Clinical practice. 5(5)
Neurologists in all practice settings will benefit from working better with insurance companies and other payers. This article discusses who the insurance companies and others are that practices should work with, why it is important to maintain and d
Publikováno v:
Neurology: Clinical Practice. 2:134-138
Health insurers look for reliable, published evidence such as evidence-based guidelines put forth by medical specialty societies to craft their coverage policies. These guidelines generate both beneficial and controversial consequences on policies. C
Publikováno v:
The Journal of Men's Health & Gender. 2:292-301
The evaluation and treatment of late-onset hypogonadism (LOH) is one of the manifold tasks of the urologist in daily practice. Diagnosis of LOH is based on an adequate history and physical examination as well as biochemical assessment of androgen def
Autor:
Wei Shen, Stephen M. Auerbach, Sanjeev Ahuja, Jay M. Young, Charles M. Beasley, Jayne A. Hague, Aileen Murphy, Carmen S. Garcia, Robert A. Feldman, Joel M. Kaufman
Publikováno v:
Journal of Andrology. 26:310-318
In a previous study assessing tadalafil for the treatment of erectile dysfunction (ED), tadalafil 20 mg was shown to improve erectile function for up to 36 hours vs placebo. This study sought to demonstrate the effectiveness of both 10- and 20-mg tad
Autor:
Joel M. Kaufman
Publikováno v:
Current Sexual Health Reports. 1:109-114
Hypogonadism, especially in aging men, is being identified and treated more frequently. Androgen replacement therapy began in the 1930s, and oral and intramuscular testosterone preparations were the primary products until the 1980s. Because of toxici
Publikováno v:
Journal of Urology. 172:658-663
We compare the efficacy of testosterone gel (T-gel) versus placebo as adjunctive therapy to sildenafil in hypogonadal men with erectile dysfunction who do not respond to sildenafil alone.A randomized, placebo controlled, double-blind, parallel group,
Autor:
Harin Padma-Nathan, Irwin Goldstein, J McMurray, Ridwan Shabsigh, Joel M. Kaufman, M Gittleman
Publikováno v:
Urology. 55:109-113
Objectives. To compare the efficacy, safety, and patient preference of intracavernously administered alprostadil alfadex and intraurethrally administered alprostadil. Methods. A crossover, randomized, open-label multicenter study of 111 patients with
Autor:
Thomas E. Weldon, Joel M. Kaufman
Publikováno v:
The Journal of Sexual Medicine. 5:2713-2715
Introduction Cylinder aneurysms and leakages are uncommon with three‐layered American Medical System (AMS) CX cylinders. Since 2001, an additional parylene coating improves cylinder wear. Aim To report two patients in whom major cylinder aneurysms
Publikováno v:
The journal of sexual medicine. 9(4)
Introduction A new formulation of testosterone gel (1.62% testosterone gel) with increased viscosity and reduced volume of application has been shown to be safe and efficacious after 182 days of use in a phase 3, double‐blind study in adult hypogon
Publikováno v:
Journal of Urology. 151:612-618
A retrospective multi-institutional study was performed to document and characterize the arterial vascular disease in the hypogastric-cavernous arterial bed and/or veno-occlusive dysfunction of the corpora cavernosa in patients with end stage renal d